Cargando…
Hyperleukocytic Acute Leukemia Circulating Exosomes Regulate HSCs and BM-MSCs
Hyperleukocytic acute leukemia (HLAL) circulating exosomes are delivered to hematopoietic stem cells (HSCs) and bone marrow mesenchymal stem cells (BM-MSCs), thereby inhibiting the normal hematopoietic process. In this paper, we have evaluated and explored the effects of miR-125b, which is carried b...
Autores principales: | Yang, Yanmei, He, Haiping, He, Jigang, Gu, Xuezhong, Hu, Peng, Zuo, Rongxia, Sa, Yalian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626181/ https://www.ncbi.nlm.nih.gov/pubmed/34840706 http://dx.doi.org/10.1155/2021/9457070 |
Ejemplares similares
-
Retracted: Hyperleukocytic Acute Leukemia Circulating Exosomes Regulate HSCs and BM-MSCs
por: Healthcare Engineering, Journal of
Publicado: (2022) -
Dexamethasone in hyperleukocytic acute myeloid leukemia
por: Bertoli, Sarah, et al.
Publicado: (2018) -
Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022) -
In Vivo Tracking and Comparison of the Therapeutic Effects of MSCs and HSCs for Liver Injury
por: Li, Qiang, et al.
Publicado: (2013) -
BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signaling
por: Zuo, Rui, et al.
Publicado: (2019)